Related Experiment Video
Updated: Feb 6, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Novel imaging techniques in pulmonary hypertension.
Christopher S Johns1, David G Kiely1, Andrew J Swift
1Sheffield Teaching Hospitals.
Noninvasive imaging, including echocardiography, CT, and MRI, aids in diagnosing pulmonary hypertension. Advanced techniques like machine learning show promise for improved diagnostic accuracy and patient assessment.
Area of Science:
- Cardiology
- Radiology
- Medical Imaging
Background:
- Pulmonary hypertension (PH) is a serious condition often linked to other diseases.
- Cardiac catheterization is the standard for PH diagnosis.
- Noninvasive imaging is gaining importance for PH assessment.
Purpose of the Study:
- To review noninvasive imaging techniques for diagnosing and assessing pulmonary hypertension.
- To explore the role of echocardiography, CT, and MRI in PH evaluation.
- To investigate the potential of modeling and machine learning in PH diagnosis.
Main Methods:
- Review of current evidence on noninvasive imaging modalities.
- Examination of echocardiography, computed tomography (CT), and magnetic resonance imaging (MRI).
- Exploration of machine learning and modeling approaches for PH diagnosis.
Main Results:
- Noninvasive imaging provides a comprehensive assessment for suspected PH.
- Echocardiography, CT, and MRI are valuable in diagnostic and prognostic evaluations.
- Machine learning demonstrates potential for enhancing PH diagnosis.
Conclusions:
- Noninvasive imaging is crucial for the initial assessment of pulmonary hypertension.
- These methods aid in diagnosis, prognosis, and treatment monitoring.
- Machine learning offers future promise for more accurate PH detection.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

